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Our data show that botulinum toxin A (BoNT/A) didn’t inﬂuence
motor functions in naïve and CCI-exposed rats, but diminished the
neuropathic pain-related behavior. The results indicate that BoNT/
A administration diminished the spinal Iba-1 positive cells acti-
vation and, in parallel, downregulated IL-1beta. Moreover, we
observed that in DRG the protein level of pronociceptive factors
(IL-1beta and IL-18) decreased and antinociceptive (IL-10 and IL-
1RA) factors increased. Additionally, our behavioral analysis shows
that chronic minocycline treatment together with a single BoNT/A
injection in CCI-exposed rats has beneﬁcial analgesic effects (M.
Zychowska, E. Rojewska, W. Makuch, S. Luvisetto, F. Pavone, S.
Marinelli, B. Przewlocka, J. Mika, 2016) [1].
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Neuroscience
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ata acquisition 1. BEHAVIORAL ANALYSIS
1.1 Tactile stimulus
1.1.1. Paw pressure test (Randall Selitto apparatus, Ugo Basile, Italy)
1.1.2. Von Frey test (Dynamic Plantar Aesthesiometer, Ugo Basile, Italy)
1.2. Thermal stimulus
1. 1.2.1 Paw withdrawal test (Hargreaves Analgesia Meter, Landing, NJ)
2. 1.2.2. Cold plate test (Hot/Cold Plate Analgesia Meter, Columbus Instruments, USA)
1.3. Motor function and activity
1.3.1. Motor function (Rota-rod apparatus, Ugo Basile, Italy)
1.3.2. Exploratory activity test (Open ﬁeld equipment)
2. BIOCHEMICAL ANALYSIS
2.1. Protein analysis
2.1.1. Western blot techniqueata format One-way analysis of variance (ANOVA) and the inter-group differences were
analyzed with Bonferroni's multiple comparison test and Student's t-test.
GraphPad Prism software (ver. 7.0).xperimental
factorsThe chemicals used were obtained from the following sources:
 Minocycline hydrochloride (MC; 30 mg/kg, i.p.) from Sigma, USA
 Botulinum neurotoxin serotype A (BoNT/A; 300 pg/paw, i.pl.), which was a
kind gift from Prof. C. Montecucco and from Prof. O. Rossetto (University of
Padova, Italy).xperimental
featuresThe experiments were carried out according to IASP rules. Neuropathic pain
model - Chronic Constriction Injury (CCI model) of the sciatic nerve was per-
formed according to Bennett and Xie (1988). Drugs intraperitoneal and intra-
plantar administration. The analgesic effect of minocycline and BoNT/A was
measured in naïve an CCI-exposed rats. The biochemical study was performed
to examine the drugs inﬂuence on CCI-induced changes on cytokines protein
level in the DRG and spinal cord.ata source
locationKrakow, Polandata accessibility Data within this articleData Value [1]
 BoNT/A, in addition to altering neuronal function, can also inﬂuence non-neuronal cells, especially
microglia.
 BoNT/A administration diminishes pro- and enhances anti-nociceptive interleukins in the spinal
cord and DRG.
 The attenuation of non-neuronal cells activation may act as an additional factor in the long-lasting
effects of BoNT/A on neuropathy.1. Data [1]
Single intraplantar BoNT/A injection signiﬁcantly attenuated pain-related behavior. Moreover,
minocycline enhanced its analgesic properties. The Western blot analysis suggests that CCI-induced
the upregulation of IL-18, IL-6 and IL-1beta protein levels in the ipsilateral lumbar spinal cord and
DRG, but no changes in IL-18BP, IL-1RA or IL-10 were observed. Interestingly, BoNT/A injection
decreased spinal and/or DRG CCI-upregulated levels of IL-18 and IL-1beta and increased the levels of
antinociceptive factors (IL-10 and IL-1RA) in the DRG (Scheme 1).
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2.1. Animals
In our experiments we used male Wistar rats from Charles River (Sulzfeld, Germany).
2.2. Neuropathic pain model
Chronic Constriction Injury model [2,3].
2.3. Drugs
 Minocycline hydrochloride (30 mg/kg intraperitoneal, Sigma, USA); scheme administration as
described before in Rojewska et al. [4]
 Botulinum neurotoxin serotype A (300 pg of toxin in 0.9% NaCl per paw; a gift from Prof. C.
Montecucco and from Prof. O. Rossetto, Padova, Italy); administration as described in Mika et al. [3]
2.4. Schemes for the study of repeated minocycline administration combined with a single BoNT/A
injection in CCI-exposed rats
MC (30 mg/kg) was administered pre-emptively via i.p. injection 16 h and 1 h before CCI and then
twice daily for seven days, referred to throughout the manuscript as repeated treatment. We had
decided on this administration schedule, since microglial cell inhibitors reduce the activation of these
cells more efﬁciently when the inhibitor is administered before an injury. On day 5 following CCI, the
i.pl. injections of 20 μl of saline (0.9% NaCl) or BoNT/A (300 pg of toxin in 0.9% NaCl per paw) were
performed. Next, on day 7 following CCI (two days after BoNT/A administration) and 30 min after the
last injection of minocycline, behavioral tests (von Frey and cold plate tests) were performed. TissueM
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Scheme 1. Graphical abstract showing the participation of pro- and anti-nociceptive interleukins in botulinum toxin
A-induced (BoNT/A) analgesia in a rat model of neuropathic pain.
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cheme 2. The way of drug administration (minocycline, MC; botulinum toxin A, BoNT/A) for behavioral and biochemical
nalysis after chronic constriction injury (CCI) to the sciatic nerve.
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